Orlaith is a partner in the Tax Group and advises a wide range of clients on the corporate tax issues arising on a broad spectrum of commercial and finance matters.

Orlaith has extensive experience advising domestic and international clients on a broad range of transactions including public and private acquisitions, disposals, mergers and joint ventures, IP on-shoring, group reorganisations and cross-border restructurings, debt and equity capital markets transactions and structured finance. Her transactional and tax advisory experience is complemented by her work on contentious tax matters including MAP processes, tax enquiries and disputes on matters such as transfer pricing and corporation tax. Previously, Orlaith practiced in a leading international law firm in the City of London. She was previously based in the firm’s New York office. 

Relevant Experience

• Advising NIQ Global Intelligence plc, the world’s leading consumer intelligence company, on its $1.05 billion IPO on the NYSE.
• Advising Mallinckrodt plc, a global leader in specialty pharmaceuticals, on its $6.7 billion merger with Endo, Inc.
• Advising Mallinckrodt plc on the sale of its Therakos business to CVC Capital Partners Fund IX for $925 million.
• Advising Investindustrial on its acquisition of DCC plc’s healthcare division for a total enterprise value of £1,050 million on a cash-free, debt-free basis.
• Advising James Hardie Industries plc, a leader in providing high-performance, low-maintenance building products and solutions, on its $8.8 billion acquisition of The AZEK Company Inc. and the transition of its secondary listing via American Depositary Receipts (ADRs) to a direct listing of ordinary shares on the NYSE.
• Advising CRH on the successful completion of its move to a US primary listing on the NYSE.
• Advising Leeds Equity Partners, a New York-based private equity firm, on the acquisition of Learnosity and Interactive Services.
• Advising Applegreen on the sale of its UK filling station business to EG On The Move.
• Advising TE Connectivity, a global industrial technology leader, on the migration of its publicly traded parent company from Switzerland to Ireland.
• Advising a lending syndicate on €350m refinancing of Dundrum Town Centre.
• Advising Archer Hotel Capital on its acquisition of the Shelbourne Hotel Dublin.
• Advising Chanelle Pharma, Ireland’s largest indigenous generic pharmaceutical manufacturer of both medical and veterinary products, on its sale to Exponent.
• Advising Viatris on the sale of its biosimilars business to Biocon for €3bn.